Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Biofrontera Inc. (BFRI) vs Universe Pharmaceuticals INC (UPC)

Biofrontera Inc. and Universe Pharmaceuticals INC are both Drug Manufacturers Specialty & Generic companies. Universe Pharmaceuticals INC is the larger, with a market value of $23.5M against $17.8M — 1.3× the size. Universe Pharmaceuticals INC has the higher net margin (−6.42% vs −13.8%) and the higher return on invested capital (0.00% vs −69.5%). Across the 15 metrics below, Universe Pharmaceuticals INC leads on 12 and Biofrontera Inc. on 3.

Valuation

Metric BFRI UPC Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.14
P/S 0.33 n/m 2.25
P/B 2.56 n/m 1.90
Price to free cash flow n/m n/m 16.54
EV/EBITDA n/m 8.52 12.29
EV/Sales 0.34 (0.24) 2.56
Earnings yield (38.14%) (30.74%) (2.99%)
Free cash flow yield (52.00%) 0.00% 0.00%

Profitability

Metric BFRI UPC Drug Manufacturers Specialty & Generic median
Gross margin 79.25% 49.77% 53.94%
Operating margin (14.22%) 0.00% 0.00%
Net margin (13.78%) (6.42%) 0.00%
Free cash flow margin (17.17%) 0.00% 0.00%
Return on equity (988.35%) 0.00% (0.40%)
Return on assets (28.80%) 0.00% (3.32%)
Return on invested capital (69.45%) 0.00% 0.00%

Growth

Metric BFRI UPC Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 17.83% — 10.01%
EPS growth (last fiscal year) 67.70% 98.71% —
Revenue growth, 5-year CAGR 17.21% (10.27%) 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BFRI UPC Drug Manufacturers Specialty & Generic median
Debt to equity 0.78 0.17 0.05
Current ratio 1.18 4.05 2.31
Net debt to EBITDA 0.17 10.15 0.85

Dividend

Metric BFRI UPC Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.70%
Payout ratio 0.00 0.00 0.00

Size

Metric BFRI UPC Drug Manufacturers Specialty & Generic median
Market cap 17.82m 23.54m 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack